Evaluating Novel Technologies for Cell Based Screening

Tid 15 Juni 2010 – 16 Juni 2010

Plats Sheraton Philadelphia City Center - USA

Speaker: Dr. Camilla Käck, Research Scientist - Attana AB Attana will present drug conjugate data using the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body. For more info about the event please visit www.worldpharmacongress.com/cba

Kategorier

  • cell
  • biosensor
  • qcm
  • label free
  • attana cell 200

Relaterad media

  • Attana Cell 200 - Label free, real time kinetics on cells, exploring biology on a new level
  • Licens: Creative Commons erkännande
    Med en Creative Commons-licens, behåller du din upphovsrätt men tillåter andra människor att kopiera och distribuera ditt verk under förutsättning att de erkänner dig som upphovsman. Du tillåter andra att kopiera, distribuera, visa och framföra verket, samt att skapa bearbetningar av det.
Ladda ner
  • Attana Cell Sensor Chip
  • Licens: Creative Commons erkännande
    Med en Creative Commons-licens, behåller du din upphovsrätt men tillåter andra människor att kopiera och distribuera ditt verk under förutsättning att de erkänner dig som upphovsman. Du tillåter andra att kopiera, distribuera, visa och framföra verket, samt att skapa bearbetningar av det.
  • Av: Attana
Ladda ner

Relaterat innehåll

Biosensor- Attana Cell 200, label free, real time kinetics on cells

Revolutionary Swedish invention can potentially improve drug development! Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

Characterisation of complex lectin-cell kinetics (Attana Application Example)

Attana Cell 200 - Label free, real time kinetics on cells, exploring biology on a new level!
 
In the development process of new pharmaceutical compounds, kinetic experiments provide insights
into potential drug candidates while also defining lead targets. In this application example we demonstrate the ability of the Attana Cell™ 200 to provide a complete and highly relevant analysis of a

PEGS 2010 with Attana!

We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!

Biotech companies - Ways to work more efficiently

Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:
Seizing funding opportunities. Companies need to broaden the search for capital to include nontraditional (and non-dilutive) sourc

Relaterade event

Attana at PEGS 2010- the essential protein engineering summit

Tid 17 Maj 2010 – 21 Maj 2010

Plats Sheraton Boston Hotel, Boston Massachusetts

Biosensors 2010 -20th Anniversary World Congress on Biosensors

Tid 26 Maj 2010 – 28 Maj 2010

Plats Scottish Conference & Exhibition Centre (SECC) Glasgow, UK

Recombinant Antibodies: Covagen AG presents the Fynomer technology

Tid 14 Juni 2010 – 18 Juni 2010

Plats The Crowne Plaza Berlin City Centre, Germany

Next Generation Protein Therapeutics

Tid 28 September 2010 – 29 September 2010

Plats Sheraton Brussels Hotel Brussels, Belgium

Discovery 2010

Tid 19 September 2010 – 21 September 2010

Plats Red Rock Casino Resort Spa, Las Vegas, USA